In a 59-year-old male with type 2 diabetes, weight 117 kg, currently on insulin glargine (Lantus) 80 units daily and receiving continuous TPN from 8 pm to 8 am containing 300 g dextrose with 123 units of regular insulin, insulin sensitivity factor 10 mg/dL per unit, insulin‑to‑carbohydrate ratio 4 g/unit, and fasting blood glucose values of 177, 209, 226, 215, and 261 mg/dL overnight, what should the basal insulin (insulin glargine) dose and the regular insulin amount in the TPN be adjusted to?

Insulin Dose Adjustments for TPN-Associated Hyperglycemia

Increase Lantus to 96 units daily (20% increase from 80 units) and increase TPN regular insulin to approximately 148 units (20% increase from 123 units) to address persistent overnight hyperglycemia with blood glucose values consistently above 180 mg/dL.

Rationale for Dose Adjustments

Your patient demonstrates clear insulin resistance with:

• All overnight blood glucose values >177 mg/dL
• Progressive rise from 177 to 261 mg/dL despite 80 units Lantus + 123 units regular insulin in TPN
• Total daily insulin dose of 203 units (1.73 units/kg for 117 kg patient)
• No oral intake, making this purely a basal + TPN nutritional insulin scenario

Basal Insulin (Lantus) Adjustment

Current dose: 80 units daily
Recommended dose: 96 units daily

The 2023 AACE guideline 1 provides clear titration guidance: when fasting blood glucose is 140-180 mg/dL, increase basal insulin by 10% of total daily dose; when >180 mg/dL, increase by 20% of total daily dose. Your patient's morning glucose of 261 mg/dL and overnight values consistently >180 mg/dL warrant the 20% increase.

The 2012 Endocrine Society guideline 2 recommends 0.4-0.5 units/kg/day for blood glucose 201-400 mg/dL in hospitalized patients. At 117 kg, this suggests 47-59 units as basal component (approximately 50% of total daily dose). Your current 80 units represents 0.68 units/kg, which is appropriate given insulin resistance, but inadequate given persistent hyperglycemia.

TPN Regular Insulin Adjustment

Current dose: 123 units for 300g dextrose (0.41 units per gram carbohydrate)
Recommended dose: 148 units (0.49 units per gram carbohydrate)

The 2018 ADA guideline 3 specifically states for parenteral feedings: "Add regular insulin to TPN IV solution, starting with 1 unit per 10 g of carbohydrate; adjust daily." Your current ratio of 0.41 units/gram is already above the starting recommendation, reflecting insulin resistance. The 2012 Endocrine Society guideline 2 confirms this approach and emphasizes daily adjustment based on blood glucose patterns.

Given the progressive overnight rise (177→209→226→215→261 mg/dL), the TPN insulin is insufficient. A 20% increase to 148 units (0.49 units/gram) aligns with the titration principles for persistent hyperglycemia >180 mg/dL 1.

Insulin Sensitivity Factor Reassessment

Current ISF: 10 mg/dL per unit
Recommended ISF: 8 mg/dL per unit (more resistant scale)

The 2012 Endocrine Society correction scale 2 provides three columns: insulin-sensitive, usual, and insulin-resistant. Your patient requires >80 units/day and demonstrates persistent hyperglycemia, placing him in the "insulin-resistant" category. The correction doses should follow the resistant column, effectively changing your ISF from 10 to approximately 8 mg/dL per unit.

For blood glucose 221-260 mg/dL, use 10 units correction (resistant column) rather than 8 units (usual column). For 261-300 mg/dL, use 12 units rather than 10 units 2.

Implementation Algorithm

1. Immediate changes:

   • Lantus: 96 units subcutaneously once daily (same time as current)
   • TPN regular insulin: 148 units mixed in TPN bag
   • Correction insulin: Use insulin-resistant scale (ISF ~8)

2. Monitoring schedule:

   • Check blood glucose every 4-6 hours during TPN infusion 3, 2
   • Document correction insulin doses administered

3. Further titration (reassess in 24-48 hours):

   • If fasting glucose remains >180 mg/dL: increase Lantus by additional 10% 1
   • If overnight glucose pattern persists >180 mg/dL: increase TPN insulin by 10-15% 3
   • If requiring >20 units total correction insulin in 24 hours: add that amount to scheduled doses (split between basal and TPN insulin) 2

Critical Safety Considerations

Hypoglycemia risk is low but monitor for:

• Blood glucose <70 mg/dL: reduce total daily dose by 10-20% 1
• Blood glucose <40 mg/dL: reduce total daily dose by 20-40% 1
• If TPN is interrupted: start 10% dextrose at 50 mL/hour to prevent hypoglycemia 4

TPN-specific risks:

• Research shows glargine use with TPN increases hypoglycemia risk compared to regular insulin alone 5, though your patient shows no hypoglycemia currently
• Longer TPN duration increases hypoglycemia risk 5—plan transition strategy when oral intake resumes
• End-organ damage from diabetes increases hypoglycemia risk 5—verify renal function

Insulin-to-Carbohydrate Ratio Verification

Your stated ICR of 4g/unit seems inconsistent with current dosing. With 300g dextrose and 123 units regular insulin, actual ratio is 2.4g/unit, indicating significant insulin resistance. This supports the aggressive dose increases recommended above.

The 2022 Endocrine Society guideline 6 notes ICR adjustments are often needed in hospital settings due to illness, infection, or insulin resistance. Your patient's obesity (117 kg) and high insulin requirements confirm marked insulin resistance requiring ratios closer to 2-2.5g/unit rather than 4g/unit.